Triclabendazole: new skills to unravel an old(ish) enigma.
about
Physiological and morphological effects of genistein against the liver fluke, Fasciola hepaticaFascioliasis and intestinal parasitoses affecting schoolchildren in Atlixco, Puebla State, Mexico: epidemiology and treatment with nitazoxanideThe diterpenoid 7-keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepaticaZoonotic helminth infections with particular emphasis on fasciolosis and other trematodiases.Characterisation of two calmodulin-like proteins from the liver fluke, Fasciola hepatica.A scanning electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.A transmission electron microscope study on the route of entry of triclabendazole into the liver fluke, Fasciola hepatica.Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukesSurvey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepaticaPopulation dynamics of the liver fluke, Fasciola hepatica: the effect of time and spatial separation on the genetic diversity of fluke populations in the Netherlands.RNAi dynamics in Juvenile Fasciola spp. Liver flukes reveals the persistence of gene silencing in vitro.Testing albendazole resistance in Fasciola hepatica: validation of an egg hatch test with isolates from South America and the United Kingdom.Efficacy of treatment of cattle for liver fluke at housing: influence of differences in flukicidal activity against juvenile Fasciola hepatica.Partial immunity to Fasciola hepatica in mice after vaccination with FhSAP2 delivered as recombinant protein or DNA construct.Gene Expression Profile in the Liver of BALB/c Mice Infected with Fasciola hepatica.Fasciola hepatica: Histology of the Reproductive Organs and Differential Effects of Triclabendazole on Drug-Sensitive and Drug-Resistant Fluke Isolates and on Flukes from Selected Field CasesFasciola hepatica: identification of CD4+ T-helper epitopes from the 11.5 kDa saposin-like protein SAP-2 using synthetic peptides.Triclabendazole for the treatment of fascioliasis and paragonimiasis.A deep exploration of the transcriptome and "excretory/secretory" proteome of adult Fascioloides magna.Calmodulin disruption impacts growth and motility in juvenile liver fluke.Anthelmintics Resistance; How to Overcome it?Triclabendazole progress report, 2005-2009: an advancement of learning?Characterisation of a novel panel of polymorphic microsatellite loci for the liver fluke, Fasciola hepatica, using a next generation sequencing approach.Microtubules as antiparasitic drug targets.Ovicidal effect of the methanolic extract of ginger (Zingiber officinale) on Fasciola hepatica eggs: an in vitro study.Efficacy of a single oral dose of oxfendazole against Fasciola hepatica in naturally infected sheepTriclabendazole Effect on Protease Enzyme Activity in the Excretory- Secretory Products of Fasciola hepatica in Vitro.Peritoneal lavage cells of Indonesian thin-tail sheep mediate antibody-dependent superoxide radical cytotoxicity in vitro against newly excysted juvenile Fasciola gigantica but not juvenile Fasciola hepaticaIn vitro efficacy of triclabendazole and clorsulon against the larval stage of Echinococcus multilocularis.Electron microscopical study to assess the in vitro effects of the synthetic trioxolane OZ78 against the liver fluke, Fasciola hepatica.Adult triclabendazole-resistant Fasciola hepatica: surface and subsurface tegumental responses to in vitro treatment with the sulphoxide metabolite of the experimental fasciolicide compound alpha.The anti-fasciolasis properties of silver nanoparticles produced by Trichoderma harzianum and their improvement of the anti-fasciolasis drug triclabendazole.Fasciola hepatica expresses multiple alpha- and beta-tubulin isotypes.Inhibition of cytochrome P450-mediated metabolism enhances ex vivo susceptibility of Fasciola hepatica to triclabendazole.FhCaBP4: a Fasciola hepatica calcium-binding protein with EF-hand and dynein light chain domains.Pochonia chlamydosporia in the biological control of Fasciola hepatica in cattle in Southeastern Brazil.Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.Adult triclabendazole-resistant Fasciola hepatica: morphological changes in the tegument and gut following in vivo treatment with artemether in the rat model.Effect of the metabolic inhibitor, methimazole on the drug susceptibility of a triclabendazole-resistant isolate of Fasciola hepatica.Seroprevalence of Fasciolagigantica infection in bovines using cysteine proteinase dot enzyme-linked immunosorbent assay.
P2860
Q28292996-0B6699D7-1B42-487D-8E2F-D93D7707EBF6Q28535341-DB60CCE7-B04E-4A08-A980-B43BDA8605D0Q28543997-248C264B-BD7F-4965-B6F8-1C98D126C6F2Q31080479-129B6CBE-3198-435F-836C-5E6B26A23077Q33286931-DBDEB8A4-0875-421E-B4C7-DE0174E9365DQ33416221-97874BC6-846A-4A9C-8A55-50D5FF2AA74AQ33520555-4B944C83-E54B-442E-B8C7-C9D3BC0BDC35Q33529290-7C52D755-8CE9-4A94-B995-76538C3D8282Q33550595-3916894E-CE8F-4805-9D0A-569C48FCE3BFQ33676277-9DFFFFCA-58F3-4C0A-88B5-5AB80EC451D3Q34257247-CE48C02F-0DEF-47EA-A073-91508EAE6DA8Q34627791-26B03327-6F0B-446A-A943-77B7AD2198F9Q35535971-64404345-0ECE-43D5-A7C9-7B266E57693AQ35678778-8692F450-5D9F-4DA5-80CA-C96228D1FFA3Q35738760-A5DD0DC4-E5E0-41BE-BAEC-1FADBB90DAB0Q36096359-B09AD2FE-2132-4C61-B699-FD05740BA8BEQ36184307-F43389BD-F9EF-42A5-A38B-7229AB71822BQ36322074-63C003A0-4697-4374-AF45-9763BF2C3A0BQ36386873-09E58186-2D5A-401A-B212-6FAB9D521350Q36513985-D0973B55-5954-4EF2-9401-19D07544870FQ36847608-36B15A8F-277A-45D0-8700-FF521AC23D84Q37444251-67489D5D-D83C-432F-BAC2-65887E2F46ABQ38958762-BD8A88E2-ED62-412F-8972-29D27B8A33ABQ39002137-34510D89-8439-4511-844E-1ADA30513A81Q40548137-369A43D7-F722-44AC-834F-0D62C229845AQ41436763-9D17F80D-664F-41E1-9F58-CE81ED3C1C88Q41509973-A087BD3D-77A8-4951-9119-7AD2C202DB0BQ42026984-E8137D16-420A-4F86-AD34-6E75514C70E9Q42272747-B0277E4F-A6F8-4C01-8D88-4B5A4D448AE6Q42458074-348AC7F0-DC03-4A0F-876B-BDF9167DF92FQ42494197-CDD10CA8-9FB2-40EB-A224-296A9E714592Q42836061-F773C91B-AC55-4CA9-B57F-3EBB09C4C604Q42918833-3F89585C-232C-48B9-AE6B-76CB39FBEDEFQ43212883-CCDFC93A-9515-458B-92CB-1AEFABE483BAQ43458659-E7367923-C703-4BB8-9FAA-1F55AC9A227FQ43458769-E64FE44F-97B0-4A4C-9D3C-B82F12142F00Q43788758-3A479BE3-C5D4-4364-9A6D-D2658615246DQ46050142-17A426BF-0471-4ADC-B0F9-209857CA7DC1Q46200030-60B87EEA-02E3-4663-B2DE-8E1B1EB3B007Q47143273-333D54C6-372E-4CA9-B331-AC1F02F202B0
P2860
Triclabendazole: new skills to unravel an old(ish) enigma.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Triclabendazole: new skills to unravel an old(ish) enigma.
@ast
Triclabendazole: new skills to unravel an old(ish) enigma.
@en
type
label
Triclabendazole: new skills to unravel an old(ish) enigma.
@ast
Triclabendazole: new skills to unravel an old(ish) enigma.
@en
prefLabel
Triclabendazole: new skills to unravel an old(ish) enigma.
@ast
Triclabendazole: new skills to unravel an old(ish) enigma.
@en
P356
P1476
Triclabendazole: new skills to unravel an old(ish) enigma.
@en
P2093
Fairweather I
P304
P356
10.1079/JOH2005298
P577
2005-09-01T00:00:00Z